Literature DB >> 8437218

Erythropoietin receptor (EpoR)-dependent mitogenicity of spleen focus-forming virus correlates with viral pathogenicity and processing of env protein but not with formation of gp52-EpoR complexes in the endoplasmic reticulum.

Y Wang1, S C Kayman, J P Li, A Pinter.   

Abstract

Recent evidence suggests that interactions between spleen focus-forming virus (SFFV) env products and the erythropoietin receptor (EpoR) are responsible for viral pathogenicity. Infection of factor-dependent cell lines expressing epoR (the cloned gene for EpoR) with SFFVP is mitogenic, generating cell lines that are no longer dependent on added growth factor, and an immunoprecipitable complex between EpoR and immature env protein in the endoplasmic reticulum has been identified. The dependence of these in vitro activities on env protein processing and their relationship to pathogenicity of SFFV were explored by using glycosylation site mutants of SFFV env. Mutants carrying Asn-->Asp mutations at each of the two consensus signals for N-linked glycosylation in the N-terminal domain of SFFVAP-L env (gs1 and gs2), the gs1-2- double mutant, and the gs0 quadruple mutant (mutated at all four signals utilized for N-linked glycosylation in SFFVAP-L env) were made. The primary translation products (gp52) of single-site mutant envs were processed into more highly glycosylated forms, and the corresponding viruses induced splenomegaly in susceptible mice, whereas the gs1-2- and gs0 proteins were not processed, and these viruses were not pathogenic. Unprocessed env proteins of both pathogenic and nonpathogenic mutants coprecipitated with EpoR. In the BaF3 cell assay for epoR-dependent mitogenicity, the pathogenic single mutants induced factor-independent growth efficiently whereas the nonpathogenic gs1-2- and gs0 mutants did not. These data demonstrate that the ability of gp52 to form complexes with EpoR in the endoplasmic reticulum is not sufficient for either mitogenicity in cell culture or induction of splenomegaly in mice while supporting the hypothesis that pathogenicity and mitogenicity of SFFV both result from an interaction between EpoR and SFFV env protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8437218      PMCID: PMC237500     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Rational design of potent antagonists to the human growth hormone receptor.

Authors:  G Fuh; B C Cunningham; R Fukunaga; S Nagata; D V Goeddel; J A Wells
Journal:  Science       Date:  1992-06-19       Impact factor: 47.728

2.  Sequence comparisons of the anemia- and polycythemia-inducing strains of Friend spleen focus-forming virus.

Authors:  L Wolff; J Kaminchik; W D Hankins; S K Ruscetti
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

3.  Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus.

Authors:  R Mann; R C Mulligan; D Baltimore
Journal:  Cell       Date:  1983-05       Impact factor: 41.582

Review 4.  Spleen focus-forming virus: relationship of an altered envelope gene to the development of a rapid erythroleukemia.

Authors:  S Ruscetti; L Wolff
Journal:  Curr Top Microbiol Immunol       Date:  1984       Impact factor: 4.291

5.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

6.  Monoclonal antibody to spleen focus-forming virus-encoded gp52 provides a probe for the amino-terminal region of retroviral envelope proteins that confers dual tropism and xenotropism.

Authors:  L Wolff; R Koller; S Ruscetti
Journal:  J Virol       Date:  1982-08       Impact factor: 5.103

7.  Envelope gene of the Friend spleen focus-forming virus: deletion and insertions in 3' gp70/p15E-encoding region have resulted in unique features in the primary structure of its protein product.

Authors:  L Wolff; E Scolnick; S Ruscetti
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

8.  Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor.

Authors:  J P Li; A D D'Andrea; H F Lodish; D Baltimore
Journal:  Nature       Date:  1990-02-22       Impact factor: 49.962

9.  Envelope gene sequences which encode the gp52 protein of spleen focus-forming virus are required for the induction of erythroid cell proliferation.

Authors:  D L Linemeyer; J G Menke; S K Ruscetti; L H Evans; E M Scolnick
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

10.  Loss of leukemogenicity caused by mutations in the membrane glycoprotein structural gene of Friend spleen focus-forming virus.

Authors:  M Ruta; R Bestwick; C Machida; D Kabat
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

View more
  9 in total

1.  Cell surface activation of the erythropoietin receptor by Friend spleen focus-forming virus gp55.

Authors:  J P Li; H O Hu; Q T Niu; C Fang
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

2.  The envelope glycoprotein of friend spleen focus-forming virus covalently interacts with and constitutively activates a truncated form of the receptor tyrosine kinase Stk.

Authors:  K Nishigaki; D Thompson; C Hanson; T Yugawa; S Ruscetti
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

3.  Sequence flexibility in the polytropic env gp70-derived region of the membrane glycoprotein (gp55) of Friend spleen focus-forming virus affects its biological activity.

Authors:  T Yugawa; H Amanuma
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

4.  Mapping of a major osteomagenic determinant of murine leukemia virus RFB-14 to non-long terminal repeat sequences.

Authors:  M Ostergaard; L Pedersen; J Schmidt; A Luz; J Lovmand; V Erfle; F S Pedersen; P G Strauss
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

5.  Glycosylation of glycoprotein 55 encoded by the anaemia-inducing strain of Friend spleen focus-forming virus.

Authors:  J Völker; H Geyer; R Geyer
Journal:  Glycoconj J       Date:  1994-04       Impact factor: 2.916

Review 6.  The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.

Authors:  S Bour; R Geleziunas; M A Wainberg
Journal:  Microbiol Rev       Date:  1995-03

7.  Selectable retrovirus vectors encoding Friend virus gp55 or erythropoietin induce polycythemia with different phenotypic expression and disease progression.

Authors:  N Ahlers; N Hunt; U Just; C Laker; W Ostertag; J Nowock
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

8.  Both the changes of six amino acids and the C-terminal truncation caused by a one-base insertion in the defective env gene of Friend spleen focus-forming virus significantly affect the pathogenic activity of the encoded leukemogenic membrane glycoprotein (gp55).

Authors:  N Watanabe; T Yugawa; Y Ikawa; H Amanuma
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

9.  Protein abundance of AKT and ERK pathway components governs cell type-specific regulation of proliferation.

Authors:  Lorenz Adlung; Sandip Kar; Marie-Christine Wagner; Bin She; Sajib Chakraborty; Jie Bao; Susen Lattermann; Melanie Boerries; Hauke Busch; Patrick Wuchter; Anthony D Ho; Jens Timmer; Marcel Schilling; Thomas Höfer; Ursula Klingmüller
Journal:  Mol Syst Biol       Date:  2017-01-24       Impact factor: 11.429

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.